Market Cap 789.77M
Revenue (ttm) 187.34M
Net Income (ttm) -9.96M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -5.32%
Debt to Equity Ratio 0.46
Volume 391,800
Avg Vol 523,636
Day's Range N/A - N/A
Shares Out 44.34M
Stochastic %K 21%
Beta 0.99
Analysts Strong Sell
Price Target $25.71

Latest News on AXGN

Axogen, Inc. (AXGN) Q4 2024 Earnings Call Transcript

Feb 25, 2025, 1:58 PM EST - 5 weeks ago

Axogen, Inc. (AXGN) Q4 2024 Earnings Call Transcript


Axogen, Inc. To Host Analyst & Investor Day on March 4th

Feb 25, 2025, 7:10 AM EST - 5 weeks ago

Axogen, Inc. To Host Analyst & Investor Day on March 4th


Axogen: Well Placed To Capitalize Growth At Higher Multiples

Jan 6, 2025, 8:01 PM EST - 3 months ago

Axogen: Well Placed To Capitalize Growth At Higher Multiples


Axogen, Inc (AXGN) Q3 2024 Earnings Call Transcript

Nov 9, 2024, 9:53 AM EST - 5 months ago

Axogen, Inc (AXGN) Q3 2024 Earnings Call Transcript


Apple, Inc. (AXGN) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 2:10 PM EDT - 8 months ago

Apple, Inc. (AXGN) Q2 2024 Earnings Call Transcript


Axogen, Inc. Announces New Leadership Appointments

Aug 8, 2024, 7:05 AM EDT - 8 months ago

Axogen, Inc. Announces New Leadership Appointments


Axogen, Inc Announces Full Launch of Avive+ Soft Tissue Matrix™

Jun 24, 2024, 7:00 AM EDT - 10 months ago

Axogen, Inc Announces Full Launch of Avive+ Soft Tissue Matrix™


AxoGen, Inc. (AXGN) Q1 2024 Earnings Call Transcript

May 5, 2024, 1:21 AM EDT - 11 months ago

AxoGen, Inc. (AXGN) Q1 2024 Earnings Call Transcript


Axogen, Inc Reports First Quarter 2024 Financial Results

May 2, 2024, 7:00 AM EDT - 11 months ago

Axogen, Inc Reports First Quarter 2024 Financial Results


AxoGen, Inc. (AXGN) Q4 2023 Earnings Call Transcript

Mar 5, 2024, 11:03 AM EST - 1 year ago

AxoGen, Inc. (AXGN) Q4 2023 Earnings Call Transcript


Axogen Announces Promotions on Research and Development Team

Jan 4, 2024, 4:35 PM EST - 1 year ago

Axogen Announces Promotions on Research and Development Team


Axogen, Inc. Appoints Kathy Weiler to its Board of Directors

Dec 26, 2023, 4:15 PM EST - 1 year ago

Axogen, Inc. Appoints Kathy Weiler to its Board of Directors


Axogen Announces Transition of Finance Team Leadership

Dec 6, 2023, 7:00 AM EST - 1 year ago

Axogen Announces Transition of Finance Team Leadership


AxoGen, Inc. (AXGN) Q3 2023 Earnings Call Transcript

Nov 7, 2023, 9:49 AM EST - 1 year ago

AxoGen, Inc. (AXGN) Q3 2023 Earnings Call Transcript


Axogen, Inc. Reports 2023 Third Quarter Financial Results

Nov 7, 2023, 7:00 AM EST - 1 year ago

Axogen, Inc. Reports 2023 Third Quarter Financial Results


Axogen to Participate at Upcoming Investor Conferences

Aug 31, 2023, 7:00 AM EDT - 1 year ago

Axogen to Participate at Upcoming Investor Conferences


AxoGen, Inc. (AXGN) Q2 2023 Earnings Call Transcript

Aug 7, 2023, 9:34 PM EDT - 1 year ago

AxoGen, Inc. (AXGN) Q2 2023 Earnings Call Transcript


Axogen, Inc. Reports 2023 Second Quarter Financial Results

Aug 7, 2023, 4:01 PM EDT - 1 year ago

Axogen, Inc. Reports 2023 Second Quarter Financial Results


Axogen to Participate at Jefferies Healthcare Conference

May 24, 2023, 7:00 AM EDT - 2 years ago

Axogen to Participate at Jefferies Healthcare Conference


AxoGen, Inc. (AXGN) Q1 2023 Earnings Call Transcript

May 9, 2023, 10:58 AM EDT - 2 years ago

AxoGen, Inc. (AXGN) Q1 2023 Earnings Call Transcript


Axogen, Inc. Reports 2023 First Quarter Financial Results

May 9, 2023, 7:00 AM EDT - 2 years ago

Axogen, Inc. Reports 2023 First Quarter Financial Results


AxoGen, Inc. (AXGN) Q4 2022 Earnings Call Transcript

Mar 14, 2023, 11:40 AM EDT - 2 years ago

AxoGen, Inc. (AXGN) Q4 2022 Earnings Call Transcript